Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 2:32 pm Purchase |
2022-12-31 | 13G | Nuvalent, Inc. NUVL |
Flynn James E | 25,471,666 39.250% |
4,777 (+0.02%) |
Filing History |
| 2023-02-10 2:31 pm Sale |
2022-12-31 | 13G | AdaptHealth Corp. AHCO |
Flynn James E | 21,673,897 5.660% |
-2,598,531 (-10.71%) |
Filing History |
| 2023-02-10 2:29 pm Sale |
2022-12-31 | 13G | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 299,362 9.070% |
-5,372 (-1.76%) |
Filing History |
| 2023-02-10 2:27 pm Purchase |
2022-12-31 | 13G | Peak Bio, Inc. PKBO |
Flynn James E | 362,500 1.780% |
362,500 (New Position) |
Filing History |
| 2023-02-10 10:11 am Unchanged |
2022-12-31 | 13G | Turmeric Acquisition Corp. TMPM |
Flynn James E | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-10 10:10 am Unchanged |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Flynn James E | 1,324,214 4.960% |
0 (Unchanged) |
Filing History |
| 2023-02-10 10:09 am Sale |
2022-12-31 | 13G | Silk Road Medical, Inc SILK |
Flynn James E | 1,396,640 3.660% |
-465,277 (-24.99%) |
Filing History |
| 2023-02-10 10:08 am Sale |
2022-12-31 | 13G | Profound Medical Corp. PROF |
Flynn James E | 0 0.000% |
-1,713,797 (Position Closed) |
Filing History |
| 2023-02-10 10:07 am Sale |
2022-12-31 | 13G | Orchard Therapeutics plc ORTX |
Flynn James E | 316,171 2.500% |
-378,771 (-54.50%) |
Filing History |
| 2023-02-10 10:06 am Sale |
2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Flynn James E | 0 0.000% |
-8,456,876 (Position Closed) |
Filing History |
| 2023-02-10 10:05 am Sale |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
Flynn James E | 2,383,000 3.560% |
-1,130,756 (-32.18%) |
Filing History |
| 2023-02-10 10:03 am Sale |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Flynn James E | 0 0.000% |
-2,344,786 (Position Closed) |
Filing History |
| 2023-02-10 10:01 am Unchanged |
2022-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
Flynn James E | 3,933,137 6.220% |
0 (Unchanged) |
Filing History |
| 2023-02-10 10:00 am Sale |
2022-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 0 0.000% |
-4,695,020 (Position Closed) |
Filing History |
| 2023-02-10 09:58 am Unchanged |
2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
Flynn James E | 1,739,130 5.060% |
0 (Unchanged) |
Filing History |
| 2023-02-10 09:45 am Sale |
2022-12-31 | 13G | IVERIC bio, Inc. ISEE |
Flynn James E | 3,424,852 2.520% |
-3,176,148 (-48.12%) |
Filing History |
| 2023-02-10 09:44 am Sale |
2022-12-31 | 13G | ImmunoGen, Inc. IMGN |
Flynn James E | 6,358,314 2.880% |
-8,421,276 (-56.98%) |
Filing History |
| 2023-02-10 09:43 am Unchanged |
2022-12-31 | 13G | Eucrates Biomedical Acquisition Corp. EUCR |
Flynn James E | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-10 09:42 am Sale |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Flynn James E | 2,349,228 3.480% |
-3,231,228 (-57.90%) |
Filing History |
| 2023-02-10 09:40 am Sale |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Flynn James E | 2,966,345 4.240% |
-2,910,460 (-49.52%) |
Filing History |